ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Jazz Pharmaceuticals
Related studies linked through entity extraction aliases.
Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
- Status
- COMPLETED
- Phase
- PHASE1
Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Defibrotide for the Treatment of Severe COVID-19
- Status
- RECRUITING
- Phase
- PHASE2
Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC
- Status
- TERMINATED
- Phase
- PHASE1
Solriamfetol in Binge Eating Disorder
- Status
- UNKNOWN
- Phase
- PHASE4
Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)
- Status
- COMPLETED
- Phase
- PHASE1
CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease
- Status
- TERMINATED
- Phase
- PHASE2
Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures
- Status
- TERMINATED
- Phase
- PHASE3
A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.
- Status
- TERMINATED
- Phase
- PHASE2
Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Language of Sleepiness
- Status
- UNKNOWN
- Phase
- N/A